January 26, 2018
A California federal judge on Thursday tossed a proposed class action accusing Takeda Pharmaceuticals America Inc. and Eli Lilly and Co. of concealing health risks associated with the diabetes treatment Actos, saying the patients previously released their claims as part of a settlement in multidistrict litigation.